Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Endocyte Inc. (ECYT)

   0 (0%)
Open: Pre. Close:
High: Low:
Volume: Market Cap: 0M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 24.012 - 24.129 24.129 - 24.229
Low: 23.705 - 23.843 23.843 - 23.961
Close: 23.787 - 23.997 23.997 - 24.179

Technical analysis

as of: 2019-03-22 4:28:49 PM
Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 28.03     One year: 32.74
Support: Support1: 23.62    Support2: 23.39
Resistance: Resistance1: 24.00    Resistance2: 28.03
Pivot: 23.91
Moving Average: MA(5): 23.99     MA(20): 23.83
MA(100): 20.32     MA(250): 14.03
MACD: MACD(12,26): 0.28     Signal(9): 0.35
Stochastic oscillator: %K(14,3): 96.22     %D(3): 97.42
RSI: RSI(14): 71.03
52-week: High: 24.00  Low: 2.81  Change(%): 439.1
Average Vol(K): 3-Month: 296668  10-Days: 154539

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
ECYT has closed below upper band by 21.6%. Bollinger Bands are 92.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to ECYT's normal range. The bands have been in this narrow range for 32 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Fri, 07 Dec 2018 15:11:32 Z
Endocyte (ECYT) Up 0.8% Since Last Earnings Report: Can It Continue?

Thu, 08 Nov 2018 01:53:43 Z
Endocyte (ECYT) Reports Q3 Loss, Tops Revenue Estimates

Mon, 22 Oct 2018 22:08:28 Z
Novartis (NVS) Q3 Earnings In Line, Revenues Beat Estimates

Fri, 19 Oct 2018 16:24:49 Z
Can The Uptrend Continue for Endocyte (ECYT)?

Thu, 18 Oct 2018 19:21:39 Z
Health Care Sector Update for 10/18/2018: ECYT,EIGR,NVS,PTI,ACRS

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Google+ Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 82.10
Shares Float (M) 79.93
% Held by Insiders 3.10
% Held by Institutions 93.50
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS -0.680
EPS Est. Current Year -1.060
EPS Est. Next Year -0.850
EPS Est. Next Quarter -0.160
Forward EPS -0.800
Book Value (p.s.) 5.670
PEG Ratio
Profit Margin
Operating Margin
Return on Assets (ttm) -17.9
Return on Equity (ttm) -18.4
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M)
Levered Free Cash Flow (M)

Stock Valuations

P/E -35.28
P/E Growth Ratio
P/BV 4.23

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.